Company Updates
PencilPay Completes Integration with NetSuite, One of the World’s Largest Cloud Business Management Software
PencilPay, the Australian software that helps small and medium suppliers act like credit providers, just announced its integration with NetSuite. NetSuite is an international cloud computing company t
Sunshine Hydro Set to Launch New Capital Raising Program Including The Flavian Superhybrid™ Project
After a successful $2M capital raise program, Queensland renewable energy company Sunshine Hydro, will be closing its current round of funding on 15th May 2022. It will be launching its $5M capital ra
Cityzenith boosts its tech strategy with high level appointments
Several high-level appointments have been made by Cityzenith as it steps up its ground-breaking strategy to cut costs and carbon emissions in the built environment.
The major signings are Dr Sam Kim,
ASX-listed company’s Silumina AnodesTM project takes next step in EV Development
Consumers are demanding that their new electric vehicles have faster-charging speeds, longer range, and, most importantly, are more affordable.
In turn, automakers are looking to find new and innovat
HealthTech announces acceptance into the government-backed MDPP
“MDPP has been incredibly valuable to Peak Medical, building and validating an MVP, giving access to Peak Medical to work with world class researchers and engineers. It is a rigorous expert panel proc
Finexia now representing a new opportunity Social Mama
Executive Summary:
‘Millennial Mothers’ accounted for approximately 90% of the 1.5 million new mothers in Australia in 2021. Increased feelings of isolation and loneliness among mothers, brought on by
Phase I Clinical Trial of RECCE® 327 Advances to High Dose Level (2,000mg I.V)
Highlights:
36 human subjects successfully dosed in the Phase I intravenous (IV) clinical trial of RECCE® 327 (R327) – good safety & tolerability
Independent Safety Committee affirms ‘low-dose’ cohor
Bolstered By Investment, Pictor Partners with Mobility Health to Offer PictArray SARS-CoV-2 Antibody Test, Indicating Whether Patients Require COVID-19 Booster
$6.1 Million investment for Pictor — led by Marko Bogoievski and K One W One Ltd. — to aid the market development of novel antibody testing and other in vitro diagnostics
EPIAXIS THERAPEUTICS APPOINTS DR DARREN SAUNDERS AS CHIEF SCIENCE OFFICER
EpiAxis Therapeutics has welcomed biomedical scientist Dr Darren Saunders as its new Chief Science Officer.
The appointment follows Dr Saunders joining EpiAxis Therapeutics in October 2021 as Science
Backed By Leading Investment Groups and Family Offices
